Evidence map›Paper›PMID 30143107›Full record

ArticleOphthalmology2018

Reply.

Mengyu Wang, Louis R Pasquale, Lucy Q Shen, Michael V Boland, Sarah R Wellik, Carlos Gustavo De Moraes, Jonathan S Myers, Hui Wang, Neda Baniasadi, Dian Li and 3 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Mengyu WangSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Louis R PasqualeMassachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Lucy Q ShenMassachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Michael V BolandWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Sarah R WellikBascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida.
Carlos Gustavo De MoraesEdward S. Harkness Eye Institute, Columbia University Medical Center, New York, New York.
Jonathan S MyersWills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Hui WangSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; Institute for Psychology and Behavior, Jilin University of Finance and Economics, Changchun, China.
Neda BaniasadiSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Dian LiSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
Rafaella Nascimento E SilvaMassachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Peter J BexDepartment of Psychology, Northeastern University, Boston, Massachusetts.
Tobias ElzeSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; Max Planck Institute for Mathematics in the Sciences, Leipzig, Germany. Electronic address: tobias-elze@tobias-elze.de.

Funding

Psychophysical Correlates of Neurodegeneration in GlaucomaR01EY018664 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI BEX, PETER JOHN · 2009 to 2012
$1.9M
Eye Movement Rehabilitation in Low Vision PatientsR01EY029713 · NEI · NORTHEASTERN UNIVERSITY · PI BEX, PETER JOHN · 2019 to 2023
$1.9M
NEI NIH HHS R01 EY018664NEI NIH HHS R01 EY029713
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlaucomaVisual FieldsHumans

Identifiers

PMID30143107
PMCPMC6706862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.